Answers are grounded in this paper and cite their sources.
Retrospective study finds high antibiotic resistance and serotype 3 prevalence in hospitalized pneumococcal patients, suggesting targeted interventions are needed for school-aged youth.
OBJECTIVES: Antimicrobial resistance (AMR) presents significant challenges for the effective treatment of pneumococcal disease (PD), disease prevalence, and vaccine effectiveness caused by S. pneumoniae. We aimed to describe the pattern of AMR among isolates from patients with PD reported in the Hong Kong population from 2012-2021, and to explore the risk factors associated with AMR among patients hospitalized with PD compared to those with susceptible isolates. METHODS: PD-related hospitalizations were identified and grouped into invasive PD (IPD) or non-IPD patients. Electronic health records were collected to calculate the healthcare resource utilization relevant to each IPD/non-IPD patient. We compared the characteristics of patients with IPD/non-IPD caused by non-susceptible isolates (cases) and those without (controls) using a multivariable logistic regression model, looking for risk factors for AMR. RESULTS: The PD incidence trend was stable from 2012 to 2019 with a sudden decrease in 2020, coinciding with the beginning of the COVID-19 pandemic. Overall, 80% of patients had S. pneumoniae non-susceptible to ≥1 antibiotic. The percentage of non-susceptibility found to tetracyclines, macrolides, penicillin, and fluoroquinolones, were 85%, 79%, 23% and 2%, respectively. Overall, 46% of the patients with serotyping results were serotype 3. Significantly increased odds of AMR infection were found among the non-IPD patients aged 2-17 years when compared to older patients (18-64 years). CONCLUSIONS: Measures to reduce non-susceptible S. pneumoniae infections should focus on children and adolescents of school age. Despite the introduction of PCV13 in 2011, serotype 3 and AMR continued to threaten people in the community. Serotype 3-infected patients accounted for nearly half of the patients with PD with serotyping results.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: